| Market Cap | 589M 507M 477M 435M 814M 56.05B 817M 5.66B 2.19B 28.56B 2.21B 2.16B 90.47B | P/E 2027 * |
-8.53x | P/E 2028 * | -19.9x |
|---|---|---|---|---|---|
| Enterprise Value | 562M 484M 456M 415M 777M 53.5B 780M 5.4B 2.09B 27.26B 2.11B 2.07B 86.35B | EV / Sales 2027 * |
0.5x | EV / Sales 2028 * | 0.47x |
| Free-Float |
97.91% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript : Tilray, Inc.
| 1 day | -5.59% |
| Manager | Title | Age | Since |
|---|---|---|---|
Irwin Simon
CEO | Chief Executive Officer | 67 | 2021-04-30 |
Carl Merton
DFI | Director of Finance/CFO | 57 | 2021-04-30 |
Roger Savell
ADM | Chief Administrative Officer | 64 | 2022-03-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Irwin Simon
CHM | Chairman | 67 | 2021-04-30 |
David Clanachan
BRD | Director/Board Member | 64 | 2021-04-29 |
John Herhalt
BRD | Director/Board Member | 69 | 2021-04-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.59% | -15.99% | - | - | 589M | ||
| +0.02% | -3.10% | +49.76% | +88.75% | 1,002B | ||
| -0.76% | -2.95% | +50.93% | +64.20% | 649B | ||
| +0.88% | -4.09% | +19.29% | +68.42% | 440B | ||
| -0.80% | -0.43% | +28.92% | +36.94% | 346B | ||
| -0.13% | -14.97% | +9.41% | +26.44% | 263B | ||
| -1.90% | -2.61% | -2.67% | +7.41% | 250B | ||
| -0.48% | -11.65% | +39.75% | +49.50% | 213B | ||
| -1.06% | -4.23% | -14.70% | -57.76% | 201B | ||
| -0.68% | -2.65% | +25.82% | +89.06% | 182B | ||
| Average | -0.94% | -2.06% | +22.94% | +41.44% | 393.74B | |
| Weighted average by Cap. | -0.17% | -2.39% | +31.99% | +55.68% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 1.12B 966M 910M 829M 1.55B 107B 1.56B 10.78B 4.17B 54.43B 4.22B 4.12B 172B | 1.18B 1.01B 953M 869M 1.63B 112B 1.63B 11.3B 4.37B 57.05B 4.42B 4.32B 181B |
| Net income | -61.49M -52.91M -49.82M -45.4M -84.94M -5.85B -85.27M -590M -228M -2.98B -231M -226M -9.44B | -26.86M -23.12M -21.77M -19.83M -37.11M -2.56B -37.25M -258M -99.7M -1.3B -101M -98.68M -4.13B |
| Net Debt | -26.8M -23.06M -21.71M -19.78M -37.01M -2.55B -37.16M -257M -99.45M -1.3B -101M -98.43M -4.12B | -39.31M -33.82M -31.85M -29.02M -54.29M -3.74B -54.51M -377M -146M -1.91B -148M -144M -6.04B |
Employees
3,595
Sector
Pharmaceuticals
















